European Medicines Agency / Provepharm SAS (Annex I to the EPAR), 2026-11-21: The SmPC identifies Provepharm SAS, Marseille, as the EU marketing authorisation holder, gives the three EU/1/11/682 presentation numbers, and dates first authorisation 6 May 2011 with latest renewal 8 February 2016.
PROVEPHARM SAS 22 rue Marc Donadille, 13013 Marseille, France 8. MARKETING AUTHORISATION NUMBER(S) EU/1/11/682/001 EU/1/11/682/002 EU/1/11/682/003 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 06 May 2011 Date of latest renewal: 08 February 2016
p.12 (sections 7-9)
European Medicines Agency / Provepharm SAS (Annex I to the EPAR), 2026-11-21: The SmPC identifies Provepharm SAS, Marseille, as the EU marketing authorisation holder, gives the three EU/1/11/682 presentation numbers, and dates first authorisation 6 May 2011 with latest renewal 8 February 2016. C7 – EU holder, document number and dates (transcribed record fields from the PDF). The excerpt reproduces sections 7-9 exactly as printed; the section headings appear in bold in the PDF and are given here as plain text, and the PDF's running text between the blocks is included. Section 11 of the package leaflet repeats the same holder name and address. Same URL as the 4.1 row; kept separate because it is the holder/number record. Fetch route: web_extract; the saved full text was grepped for 'PROVEPHARM' to locate sections 7-9 on p.12. document_date: access date, page undated (the SmPC prints no revision date). Also filed as MTH-039 (claims C7). Study type: regulatory record.
